News

The patent infringement suit surrounding Sanofi-Aventis’s Plavix, the world’s third largest selling medication, was previously scheduled for May 13, 2005. Canadian company Apotex and India’s Dr Reddy’s Laboratories,

The five-year agreement begins on June 1 and provides for strong revenue growth for Derma Science, as well as incentives to Source Medical. In addition to distribution fees

The data show that the vaccine induces an immune response potentially capable of eradicating cells infected by highly divergent influenza viruses. It also has the potential to augment

The lost contract was worth up to $70 million a year, according to The Guardian, but AstraZeneca is said to have taken the news well, remaining confident about

Uracyst is formulated to treat interstitial cystitis (IC), an inflammatory disease of the urinary wall, the most common symptom of which is the need to urgently and frequently

Building on leads generated from Southern Research’s proprietary compound repository, scientists from both companies will interact closely as a drug discovery team in a lead expansion and optimization

Viragen recently reported that the anti-CD55 antibody, known as VG102, was able to enhance the action of Genentech and Biogen Idec’s Rituxan (rituximab), resulting in the significant increase

The study compared Aurexis plus antibiotic therapy to antibiotic therapy alone. Favorable results were observed in the primary composite endpoint of mortality, relapse rate and infection-related complications, and

Under the new agreement, Novavax will manufacture Estrasorb, a topical emulsion for estrogen therapy, and Cardinal Health will be responsible for the fill-finish operation that prepares Estrasorb in